This inventor holds 1 USPTO granted patent. Top assignee: Biomerieux, Inc.. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Françoise Guillou-Bonnici: Innovator in Nucleotide Amplification
Introduction
Françoise Guillou-Bonnici is a notable inventor based in Villeurbanne, France. He has made significant contributions to the field of biotechnology, particularly in the area of nucleotide amplification. His innovative work has led to the development of a unique method that enhances the efficiency of amplifying target nucleic acid sequences.
Latest Patents
Guillou-Bonnici holds a patent for a method titled "Prefunctionalized nucleotide and process for amplifying a sequence using a prefunctionalized nucleotide." This patent describes a target nucleic acid sequence amplification method that involves the use of at least one prefunctionalized nucleotide. The method allows for the amplification of a target sequence under specific conditions suitable for enzymatic activities, thereby improving the overall efficiency of the amplification process.
Career Highlights
Françoise Guillou-Bonnici is associated with Biomerieux, Inc., a company renowned for its advancements in the field of diagnostics and biotechnology. His work at Biomerieux has allowed him to apply his innovative ideas in a practical setting, contributing to the development of cutting-edge technologies in the industry.
Collaborations
Throughout his career, Guillou-Bonnici has collaborated with esteemed colleagues such as Ali Laayoun and Jean Lhomme. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.
Conclusion
Françoise Guillou-Bonnici's contributions to nucleotide amplification represent a significant advancement in biotechnology. His innovative methods and collaborations continue to influence the field, showcasing the importance of research and development in driving scientific progress.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
